Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Suppression of Tumor Growth and Cell Migration by Indole-Based Benzenesulfonamides and Their Synergistic Effects in Combination with Doxorubicin
Phuong Linh Nguyen, Ahmed Elkamhawy, Young Hee Choi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9903-9903
Open Access | Times Cited: 13

Showing 13 citing articles:

Hypoxia-Inducible Factor-1: A Novel Therapeutic Target for the Management of Cancer, Drug Resistance, and Cancer-Related Pain
Bich Phuong Bui, Phuong Linh Nguyen, Kyeong Lee, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6054-6054
Open Access | Times Cited: 73
Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations
Ahmed A. Al‐Karmalawy, Mohamed S. Nafie, Moataz A. Shaldam, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 777-792
Closed Access | Times Cited: 42
Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery—An Updated Review on Their Multifaceted Therapeutic Applications (2020–2024)
Xingyou Mo, Devendra Pratap Rao, Kirandeep Kaur, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4770-4770
Open Access | Times Cited: 6
Combination of Nanovectorized siRNA Directed against Survivin with Doxorubicin for Efficient Anti-Cancer Activity in HER2+ Breast Cancer Cells
Sahar Eljack, Émilie Allard-Vannier, Yoann Misericordia, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2537-2537
Open Access | Times Cited: 11
Inhibitory Effects of Urolithins, Bioactive Gut Metabolites from Natural Polyphenols, against Glioblastoma Progression
Ching‐Kai Shen, Bor‐Ren Huang, Vichuda Charoensaensuk, et al.
Nutrients (2023) Vol. 15, Iss. 23, pp. 4854-4854
Open Access | Times Cited: 5
Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells
Angela Filograna, Stefano De Tito, Matteo Lo Monte, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Combined In Silico and In Vitro Analyses to Assess the Anticancer Potential of Thiazolidinedione–Thiosemicarbazone Hybrid Molecules
Agata Paneth, Barbara Kaproń, Tomasz Plech, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17521-17521
Open Access | Times Cited: 3
The anti‐breast cancer potential of indole/isatin hybrids
Ruo Wang, Renhong Huang, Yaofeng Yuan, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 11
Closed Access | Times Cited: 2
Biological activity of a benzene sulfonamide on perfusion pressure and coronary resistance using an isolated rat heart model
Magdalena Alvarez-Ramirez, Lauro Figueroa-Valverde, Rosas‐Nexticapa Marcela, et al.
Brazilian Journal of Science (2024) Vol. 3, Iss. 4, pp. 11-23
Open Access
Current Scenario of Sulfonamide Hybrids with Anti-Breast Cancer Therapeutic Applications: I. Sulfonamide-Five-Membered Heterocycle Hybrids
Zhi Xu, Mengyu Ma
Russian Journal of General Chemistry (2024) Vol. 94, Iss. 5, pp. 1191-1206
Closed Access
Recent Progress of Sulfonamide-Indole/Carbazole Hybrids with the Anticancer Potential (A Review)
Ye Wang, Chaoyin Liu, Zhi Xu
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 5, pp. 2024-2035
Closed Access
Progress of Section “Biochemistry” in 2022
Claudiu T. Supuran
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5873-5873
Open Access
Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells
Angela Filograna, Stefano De Tito, Matteo Lo Monte, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top